← Browse by Condition
Medical Condition
pdac
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 1, Phase 2
NCT07349537 Phase 1
Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Enrollment
574 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.